More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.
What's New With WIRED
More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.
00:00 / 03:25